Shopping Cart 0
Cart Subtotal
AED 0

Esoteric Testing Market: Current Analysis and Forecast (2021-2027)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 18346

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 21282

Details

Esoteric testing is the examination of uncommon chemicals or molecules that are not detected in conventional clinical laboratory tests. Endocrinology, genetics, immunology, microbiology, molecular diagnostics, oncology, serology, and toxicology are some of the areas where esoteric testing is performed. In-house esoteric testing is usually outsourced to independent and specialized clinical reference laboratories.

Over the forecast period, the market will be driven by an increase in the frequency of rare and complex diseases, as well as increased awareness about early disease detection and treatment. According to the European Commission, rare diseases affect nearly 27 to 36 million individuals throughout Europe. The rapidly growing healthcare sector in developing countries, as well as an increase in the number of sophisticated laboratories providing advanced services, will help the industry flourish. The growing number of baby boomers who are susceptible to a variety of chronic illnesses will have a significant impact on industry growth. North America and Asia-Pacific would be the top two markets for Esoteric Testing, owing to the increasing patient population suffering from chronic diseases and rising increased adoption of rapid diagnostics. Based on type the global Esoteric Testing market is bifurcated into infectious diseases testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and others. Currently, the infectious diseases testing segment dominates the market and is expected to maintain its dominance during the forecast period. The largest share of the segment is attributed to the increasing incidence of infectious diseases, technological innovations in molecular diagnostics, and improving healthcare infrastructure in developing nations.

Based on technology the market is divided into Power line chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, flow cytometry, radioimmunoassay, and others. The chemiluminescence immunoassay segment dominated the market in 2020 owing to its advantages over other testing methods, such as high-performance levels, low detection limits; etc.

Based on end-user the market is bifurcated into independent & reference laboratories, research laboratories, and hospital-based laboratories. Currently independent & reference laboratories segment dominates the market and is expected to maintain its dominance during the analyzed period owing to the presence of improved diagnostic equipment and devices.

For a better understanding of the market adoption, the report provides detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for esoteric testing owing to the advanced technology for diagnosis and treatment of chronic disorders, availability of private and government funding, etc.

Some of the major players operating in the market include LabCorp, Quest Diagnostics, Invitae Corporation, Mayo Medical Laboratories, Spectra Laboratories, Opko Health, Miraca Holdings, Foundation Medicine, Myriad Genetics, and Sonic Healthcare.

Global Esoteric Testing Market was valued at USD XX billion in 2020 and is projected to expand significantly with a CAGR of XX% from 2021-2027F. The Global Esoteric Testing Market is expected to witness a boost on account of the increasing prevalence of rare and infectious diseases.

READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Esoteric Testing Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Esoteric Testing Market

2.1.1 Main Objective of the Global Esoteric Testing Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER ESOTERIC TESTING INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL ESOTERIC TESTING MARKET REVENUE

8 MARKET INSIGHTS BY TYPES

8.1 Infectious Diseases Testing

8.2 Endocrinology Testing

8.3 Oncology Testing

8.4 Genetic Testing

8.5 Toxicology Testing

8.6 Immunology Testing

8.7 Neurology Testing

9 MARKET INSIGHTS BY TECHNOLOGY

9.1 Chemiluminescence Immunoassay

9.2 Enzyme-Linked Immunosorbent Assay

9.3 Mass Spectrometry

9.4 Real-Time PCR

9.5 Flow Cytometry

9.6 Radioimmunoassay

9.7 Others

10 MARKET INSIGHTS BY END-USER

10.1 Independent & Reference Laboratories

10.2 Research Laboratories

10.3 Hospital based laboratories

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA ESOTERIC TESTING MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE ESOTERIC TESTING MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC ESOTERIC TESTING MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.6 Rest of Asia Pacific

11.4 REST OF THE WORLD ESOTERIC TESTING MARKET

12 ESOTERIC TESTING MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 ESOTERIC TESTING MARKET OPPORTUNITIES

17 ESOTERIC TESTING MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Myriad Genetics

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1 Revenue Split

19.1.6.2 Financial Overview of Medtronics plc

19.1.7 Recent Developments

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 LabCorp

19.3 Quest Diagnostics

19.4 Invitae Corporation

19.5 Mayo Medical Laboratories

19.6 Spectra Laboratories

19.7 Opko Health

19.8 Miraca Holdings

19.9 Foundation Medicine

19.10 Sonic Healthcare

20 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

LabCorp

Quest Diagnostics

Invitae Corporation

Mayo Medical Laboratories

Spectra Laboratories

Opko Health

Miraca Holdings

Foundation Medicine

Myriad Genetics

and Sonic Healthcare

Company Profile

Company Profile Title

Esoteric testing is the examination of uncommon chemicals or molecules that are not detected in conventional clinical laboratory tests. Endocrinology, genetics, immunology, microbiology, molecular diagnostics, oncology, serology, and toxicology are some of the areas where esoteric testing is performed. In-house esoteric testing is usually outsourced to independent and specialized clinical reference laboratories.

Over the forecast period, the market will be driven by an increase in the frequency of rare and complex diseases, as well as increased awareness about early disease detection and treatment. According to the European Commission, rare diseases affect nearly 27 to 36 million individuals throughout Europe. The rapidly growing healthcare sector in developing countries, as well as an increase in the number of sophisticated laboratories providing advanced services, will help the industry flourish. The growing number of baby boomers who are susceptible to a variety of chronic illnesses will have a significant impact on industry growth. North America and Asia-Pacific would be the top two markets for Esoteric Testing, owing to the increasing patient population suffering from chronic diseases and rising increased adoption of rapid diagnostics. Based on type the global Esoteric Testing market is bifurcated into infectious diseases testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and others. Currently, the infectious diseases testing segment dominates the market and is expected to maintain its dominance during the forecast period. The largest share of the segment is attributed to the increasing incidence of infectious diseases, technological innovations in molecular diagnostics, and improving healthcare infrastructure in developing nations.

Based on technology the market is divided into Power line chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, flow cytometry, radioimmunoassay, and others. The chemiluminescence immunoassay segment dominated the market in 2020 owing to its advantages over other testing methods, such as high-performance levels, low detection limits; etc.

Based on end-user the market is bifurcated into independent & reference laboratories, research laboratories, and hospital-based laboratories. Currently independent & reference laboratories segment dominates the market and is expected to maintain its dominance during the analyzed period owing to the presence of improved diagnostic equipment and devices.

For a better understanding of the market adoption, the report provides detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for esoteric testing owing to the advanced technology for diagnosis and treatment of chronic disorders, availability of private and government funding, etc.

Some of the major players operating in the market include LabCorp, Quest Diagnostics, Invitae Corporation, Mayo Medical Laboratories, Spectra Laboratories, Opko Health, Miraca Holdings, Foundation Medicine, Myriad Genetics, and Sonic Healthcare.

Global Esoteric Testing Market was valued at USD XX billion in 2020 and is projected to expand significantly with a CAGR of XX% from 2021-2027F. The Global Esoteric Testing Market is expected to witness a boost on account of the increasing prevalence of rare and infectious diseases.

READ MORE

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Esoteric Testing Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Esoteric Testing Market

2.1.1 Main Objective of the Global Esoteric Testing Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER ESOTERIC TESTING INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL ESOTERIC TESTING MARKET REVENUE

8 MARKET INSIGHTS BY TYPES

8.1 Infectious Diseases Testing

8.2 Endocrinology Testing

8.3 Oncology Testing

8.4 Genetic Testing

8.5 Toxicology Testing

8.6 Immunology Testing

8.7 Neurology Testing

9 MARKET INSIGHTS BY TECHNOLOGY

9.1 Chemiluminescence Immunoassay

9.2 Enzyme-Linked Immunosorbent Assay

9.3 Mass Spectrometry

9.4 Real-Time PCR

9.5 Flow Cytometry

9.6 Radioimmunoassay

9.7 Others

10 MARKET INSIGHTS BY END-USER

10.1 Independent & Reference Laboratories

10.2 Research Laboratories

10.3 Hospital based laboratories

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA ESOTERIC TESTING MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE ESOTERIC TESTING MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC ESOTERIC TESTING MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.6 Rest of Asia Pacific

11.4 REST OF THE WORLD ESOTERIC TESTING MARKET

12 ESOTERIC TESTING MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 ESOTERIC TESTING MARKET OPPORTUNITIES

17 ESOTERIC TESTING MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Myriad Genetics

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1 Revenue Split

19.1.6.2 Financial Overview of Medtronics plc

19.1.7 Recent Developments

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 LabCorp

19.3 Quest Diagnostics

19.4 Invitae Corporation

19.5 Mayo Medical Laboratories

19.6 Spectra Laboratories

19.7 Opko Health

19.8 Miraca Holdings

19.9 Foundation Medicine

19.10 Sonic Healthcare

20 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

LabCorp

Quest Diagnostics

Invitae Corporation

Mayo Medical Laboratories

Spectra Laboratories

Opko Health

Miraca Holdings

Foundation Medicine

Myriad Genetics

and Sonic Healthcare